Prognostic implications of intraoperative radiotherapy for unresectable pancreatic cancer

Pancreatology

Volumn 11, Issue 1, 2011, Pages 68-75

  Nagai, Shunji ^a   Fujii, Tsutomu ^a   Kodera, Yasuhiro ^a   Kanda, Mitsuro ^a   Sahin, Tevfik T ^a   Kanzaki, Akiyuki ^a   Yamada, Suguru ^a   Sugimoto, Hiroyuki ^a   Nomoto, Shuji ^a   Takeda, Shin ^a   Morita, Satoshi ^b   Nakao, Akimasa ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

Author keywords

Intraoperative radiotherapy; Liver metastasis; Locally advanced tumor; Peritoneal metastasis; Postoperative chemotherapy; Unresectable pancreatic cancer

Indexed keywords

FLUOROURACIL; GEMCITABINE; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR; MITOMYCIN C;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; FEMALE; HUMAN; INOPERABLE CANCER; INTRAOPERATIVE RADIOTHERAPY; LAPAROTOMY; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PANCREAS CANCER; PERITONEUM METASTASIS; PRIORITY JOURNAL; PROGNOSIS; TUMOR LOCALIZATION;

EID: 79955125724     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000324682     Document Type: Article

References (33)

1. Evans DB, Abbruzzese JL, Willett CG: Cancer of the Pancreas. Philadelphia, Lippincott- Reiner, 2000.
2. Wilkowski R, Wolf M, Heinemann V: Primary advanced unresectable pancreatic cancer. Recent Results Cancer Res 2008; 177: 79-93.
3. Crane CH, Beddar AS, Evans DB: The role of intraoperative radiotherapy in pancreatic cancer. Surg Oncol Clin N Am 2003; 12: 965-977. (Pubitemid 37456568)
4. Higashi T, Sakahara H, Torizuka T, Nakamoto Y, Kanamori S, Hiraoka M, Imamura M, Nishimura Y, Tamaki N, Konishi J: Evaluation of intraoperative radiation therapy for unresectable pancreatic cancer with FDG PET. J Nucl Med 1999; 40: 1424-1433. (Pubitemid 29428922)
5. Nakao A, Harada A, Nonami T, Kaneko T, Takeda S, Kurokawa T, Ishigaki T, Takagi H: Intraoperative radiotherapy for pancreatic carcinoma with hepatic or peritoneal metastases. Hepatogastroenterology 1997; 44: 1469-1471. (Pubitemid 27450197)
6. Ruano-Ravina A, Almazan Ortega R, Guedea F: Intraoperative radiotherapy in pancreatic cancer: a systematic review. Radiother Oncol 2008; 87: 318-325.
7. Showalter TN, Rao AS, Rani Anne P, Rosato FE, Rosato EL, Andrel J, Hyslop T, Xu X, Berger AC: Does intraoperative radiation therapy improve local tumor control in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma? A propensity score analysis. Ann Surg Oncol 2009; 16: 2116-2122.
8. Valentini V, Calvo F, Reni M, Krempien R, Sedlmayer F, Buchler MW, Di Carlo V, Doglietto GB, Fastner G, Garcia-Sabrido JL, Mattiucci G, Morganti AG, Passoni P, Roeder F, D'Agostino GR: Intra-operative radiotherapy (IORT) in pancreatic cancer: joint analysis of the ISIORT-Europe experience. Radiother Oncol 2009; 91: 54-59.
9. Valentini V, Morganti AG, Macchia G, Mantini G, Mattiucci GC, Brizi MG, Alfieri S, Bossola M, Pacelli F, Sofo L, Doglietto G, Cellini N: Intraoperative radiation therapy in resected pancreatic carcinoma: long-term analysis. Int J Radiat Oncol Biol Phys 2008; 70: 1094-1099. (Pubitemid 351296100)
10. Willett CG, Del Castillo CF, Shih HA, Goldberg S, Biggs P, Clark JW, Lauwers G, Ryan DP, Zhu AX, Warshaw AL: Long-term results of intraoperative electron beam irradiation (IOERT) for patients with unresectable pancreatic cancer. Ann Surg 2005; 241: 295-299.
11. Yamaue H, Tanimura H, Aoki Y, Tsunoda T, Iwahashi M, Tani M, Tamai M, Noguchi K, Kashiwagi H, Sasaki M, et al: Clinical and immunological evaluation of intraoperative radiation therapy for patients with unresectable pancreatic cancer. J Surg Oncol 1992; 49: 10-15.
12. Nakao A, Harada A, Nonami T, Kaneko T, Inoue S, Takagi H: Intraoperative radiotherapy for resectable and unresectable pancreatic cancer. J Hepatobiliary Pancreat Surg 1994; 1: 252-256.
13. Hiraoka T, Kanemitsu K: Value of extended resection and intraoperative radiotherapy for resectable pancreatic cancer. World J Surg 1999; 23: 930-936. (Pubitemid 29398476)
14. Nakao A, Kaneko T: Intravascular ultrasonography for assessment of portal vein invasion by pancreatic carcinoma. World J Surg 1999; 23: 892-895. (Pubitemid 29398469)
15. Kaneko T, Nakao A, Inoue S, Harada A, Nonami T, Itoh S, Endo T, Takagi H: Intraportal endovascular ultrasonography in the diagnosis of portal vein invasion by pancreatobiliary carcinoma. Ann Surg 1995; 222: 711-718. (Pubitemid 26001234)
16. Kaneko T, Nakao A, Harada A, Nomami T, Takagi H: Intraportal endovascular ultrasonography in pancreatic cancer - a new technique for the diagnosis of portal vein invasion: a preliminary report. Surgery 1994; 115: 438-444. (Pubitemid 24123631)
17. Nakai Y, Isayama H, Sasaki T, Sasahira N, Ito Y, Kogure H, Togawa O, Matsubara S, Arizumi T, Yagioka H, Yashima Y, Kawakubo K, Mizuno S, Yamamoto K, Hirano K, Tsujino T, Ijichi H, Toda N, Tada M, Kawabe T, Omata M: A pilot study for combination chemotherapy using gemcitabine and S-1 for advanced pancreatic cancer. Oncology 2009; 77: 300-303.
18. Oh DY, Cha Y, Choi IS, Yoon SY, Choi IK, Kim JH, Oh SC, Kim CD, Kim JS, Bang YJ, Kim YH: A multicenter phase II study of gemcitabine and S-1 combination chemotherapy in patients with unresectable pancreatic cancer. Cancer Chemother Pharmacol 2010; 65: 527-536.
19. Oettle H, Neuhaus P: Adjuvant therapy in pancreatic cancer: a critical appraisal. Drugs 2007; 67: 2293-2310. (Pubitemid 350071043)
20. Regine WF, Winter KA, Abrams RA, Safran H, Hoffman JP, Konski A, Benson AB, Macdonald JS, Kudrimoti MR, Fromm ML, Haddock MG, Schaefer P, Willett CG, Rich TA: Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial. JAMA 2008; 299: 1019-1026. (Pubitemid 351347058)
21. Kamath A, Yoo D, Stuart OA, Bijelic L, Sugarbaker PH: Rationale for an intraperitoneal gemcitabine chemotherapy treatment for patients with resected pancreatic cancer. Recent Pat Anticancer Drug Discov 2009; 4: 174-179.
22. Kouloulias VE, Nikita KS, Kouvaris JR, Golematis BC, Uzunoglu NK, Mystakidou K, Vlahos LJ: Intraoperative hyperthermia and chemoradiotherapy for inoperable pancreatic carcinoma. Eur J Cancer Care (Engl) 2002; 11: 100-107.
23. Matsuno S, Egawa S, Fukuyama S, Motoi F, Sunamura M, Isaji S, Imaizumi T, Okada S, Kato H, Suda K, Nakao A, Hiraoka T, Hosotani R, Takeda K: Pancreatic cancer registry in Japan: 20 years of experience. Pancreas 2004; 28: 219-230. (Pubitemid 38437313)
24. Ueno H, Kosuge T, Matsuyama Y, Yamamoto J, Nakao A, Egawa S, Doi R, Monden M, Hatori T, Tanaka M, Shimada M, Kanemitsu K: A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese study group of adjuvant therapy for pancreatic cancer. Br J Cancer 2009; 101: 908-915.
25. Sindelar WF, Kinsella TJ: Studies of intraoperative radiotherapy in carcinoma of the pancreas. Ann Oncol 1999; 10(suppl 4):226-230.
26. Neoptolemos JP, Stocken DD, Tudur Smith C, Bassi C, Ghaneh P, Owen E, Moore M, Padbury R, Doi R, Smith D, Buchler MW: Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and -3(v1) trials. Br J Cancer 2009; 100: 246-250.
27. Neoptolemos JP, Stocken DD, Friess H, Bassi C, Dunn JA, Hickey H, Beger H, Fernandez- Cruz L, Dervenis C, Lacaine F, Falconi M, Pederzoli P, Pap A, Spooner D, Kerr DJ, Buchler MW: A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 2004; 350: 1200-1210. (Pubitemid 38339364)
28. Ohigashi H, Ishikawa O, Eguchi H, Takahashi H, Gotoh K, Yamada T, Yano M, Nakaizumi A, Uehara H, Tomita Y, Nishiyama K: Feasibility and efficacy of combination therapy with preoperative full-dose gemcitabine, concurrent three-dimensional conformal radiation, surgery, and postoperative liver perfusion chemotherapy for T3-pancreatic cancer. Ann Surg 2009; 250: 88-95.
29. Moore MJ, Hamm J, Dancey J, Eisenberg PD, Dagenais M, Fields A, Hagan K, Greenberg B, Colwell B, Zee B, Tu D, Ottaway J, Humphrey R, Seymour L: Comparison of gemcitabine versus the matrix metalloproteinase inhibitor BAY 12-9566 in patients with advanced or metastatic adenocarcinoma of the pancreas: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 2003; 21: 3296-3302. (Pubitemid 46606263)
30. Farrell TJ, Barbot DJ, Rosato FE: Pancreatic resection combined with intraoperative radiation therapy for pancreatic cancer. Ann Surg 1997; 226: 66-69. (Pubitemid 27468905)
31. Shimizu Y, Yasui K, Fuwa N, Arai Y, Yamao K: Late complication in patients undergoing pancreatic resection with intraoperative radiation therapy: gastrointestinal bleeding with occlusion of the portal system. J Gastroenterol Hepatol 2005; 20: 1235-1240. (Pubitemid 41602567)
32. Saidi RF, Jacobs MJ: Adjuvant interferonbased chemoradiation followed by gemcitabine for resected pancreatic adenocarcinoma. Ann Surg 2009; 249: 865; author reply 865-866.
33. Nakayama S, Takeda S, Kawase Y, Inoue S, Kaneko T, Nakao A: Clinical significance of dihydropyrimidine dehydrogenase in adjuvant 5-fluorouracil liver perfusion chemotherapy for pancreatic cancer. Ann Surg 2004; 240: 840-844. (Pubitemid 39425777)